SG7 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - SAGE Therapeutics Inc

Watchlist Manager

Watchlist

Price: 7.598 EUR 1.12%

Market Cap: €457.3m

S	SAGE Therapeutics Inc SWB:SG7	US
	McCormick & Company Inc F:MCX0	US
P	Primeenergy Resources Corp F:PEJ	US
	Opawica Explorations Inc F:OE5	CA
	ZTO Express (Cayman) Inc LSE:0A33	CN
	Dicker Data Ltd F:D0D	AU
O	Orkla ASA DUS:OKL	NO

Profitability Summary

SAGE Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Strong 3Y Average Gross Margin

80%

Negative Operating Margin

-430%

Negative 3Y Average Operating Margin

-1 778%

Operating Margin is Increasing

-5 975% > -430%

Negative Net Margin

-428%

Negative 3Y Average Net Margin

-1 727%

Net Margin is Increasing

-5 688% > -428%

Negative Free Cash Flow Margin

-411%

Negative 3Y Average Free Cash Flow Margin

-1 491%

Free Cash Flow Margin is Increasing

-5 114% > -411%

Negative ROE

-60%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-750%

ROIC is Increasing

-814% > -616%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.